Agreed.
NPV of approx. $176m AUD ($125m USD) based on $63/lb USD vs $171m AUD implied enterprise value ($204m M-Cap subtract $11m AUD cash and $22m AUD of U3O8 Inventory).
If you take the project NPV at the current spot price, the NPV gets down to approx $50m AUD which would imply PEN is drastically overvalued at current spot prices. There is only value if you have a bullish view on uranium spot prices.
I struggle to find the logic in holding a company with all the production and AISC risks, when you could just own Sprott if you are bullish on uranium prices.
Unless I am missing something, happy to be corrected.
- Forums
- ASX - By Stock
- PEN
- Ann: Presentation - DFS Completed for Lance
PEN
peninsula energy limited
Add to My Watchlist
0.00%
!
62.0¢

Ann: Presentation - DFS Completed for Lance, page-28
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
62.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $98.97M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PEN (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online